AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Mylimus 0.1% Ointment

Prescription Icon
Prescription Required

Marketer

Mylan Pharmaceuticals Pvt Ltd - A Viatris Company

Salt Composition

Tacrolimus (0.1% w/w)

Overview Mylimus 0.1% Ointment

Topical Mylimus 0.1% ointment effectively manages atopic dermatitis (eczema) by modulating the immune response. Its mechanism involves reducing the inflammatory activity of specific immune cells, thereby lessening skin redness, swelling, and itching, and improving rash appearance. Apply thinly and evenly to affected areas 2-4 times daily, or as directed by your physician. Avoid over-application and occlusive dressings. Seek medical advice if no improvement is seen after a fortnight or if your condition worsens. Potential side effects include skin redness (erythema), headache, folliculitis, and localized reactions such as burning, irritation, itching, and redness at the application site. Use during pregnancy or breastfeeding should only occur under strict medical supervision.

Primary Ingredients of Mylimus 0.1% Ointment

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Mylimus 0.1% Ointment

Managing atopic eczema

Major Benefits of Mylimus 0.1% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application details. Before applying, ensure the affected skin is clean and dry, then gently rub in the ointment.

Common Side effects of Mylimus 0.1% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Mylimus 0.1% Ointment:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label for application details. Ensure the affected skin is clean and dry before gently rubbing in the ointment.

How Mylimus 0.1% Ointment works:

Mylimus 0.1% Ointment, an immunosuppressive topical agent, reduces skin inflammation—manifested as redness and swelling—by modulating the activity of specific immune cells. This action alleviates itching and improves the appearance of rashes associated with atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Mylimus 0.1% Ointment during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to any prescription. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The application of Mylimus 0.1% Ointment while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Mylimus 0.1% Ointment :

Apply Mylimus 0.1% Ointment as soon as you remember a missed dose. If your next application is nearly due, however, omit the forgotten dose and resume your usual dosing regimen.

Facts to Know About Mylimus 0.1% Ointment

LabelValue
Chemical Category Macrolide antibiotics
Developing Habits No.
Type of Therapy Cancer Medications
Actions Calcineurin inhibitor immunosuppressants

FAQs on Mylimus 0.1% Ointment

Mylimus 0.1% Ointment is an immune-modulating medication that primarily reduces immune system activity. It treats moderate to severe eczema (atopic dermatitis) in adults whose condition is unresponsive to, or adversely affected by, steroid treatments. Eczema involves an overactive skin immune response causing inflammation, itching, redness, and dryness. Mylimus 0.1% Ointment targets this abnormal immune response, thereby alleviating inflammation and itching.
Applying Mylimus 0.1% Ointment may cause mild to moderate skin irritation, including burning, itching, redness, warmth, pain, altered sensation, and rash at the application site. These side effects usually subside within a week. Treatment may also increase the risk of inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Mylimus 0.1% Ointment offers safe and effective short-term atopic dermatitis treatment, demonstrating superior safety compared to other immunosuppressants. Minimal systemic absorption following topical application results in fewer side effects than oral administration.
Mylimus 0.1% Ointment is not a controlled substance and does not have abuse potential. Controlled substances require authorization from both a doctor and regulatory authorities due to their risk of misuse.
Prolonged use of Mylimus 0.1% Ointment is associated with an increased lymphoma risk (a type of lymph node tumor). Studies indicate a small number of users of Mylimus 0.1% Ointment or similar medications developed skin cancer or lymphoma. If using Mylimus 0.1% Ointment for over six weeks, or if your eczema worsens or fails to improve, consult your physician.
Mylimus 0.1% Ointment is a non-steroid medication that modulates the immune system. Primarily used for eczema, especially atopic dermatitis, it avoids the skin thinning and other side effects associated with steroids.
Mylimus 0.1% Ointment
298
MRP 345
13% off